Retrospective Study
Copyright ©The Author(s) 2021.
World J Gastrointest Surg. Jan 27, 2021; 13(1): 50-75
Published online Jan 27, 2021. doi: 10.4240/wjgs.v13.i1.50
Table 8 Demographic and patient-related preoperative potential prognostic factors for liver and lung recurrence

Recurrence, n = 58
Liver
Lung
No, n = 33 (55.0%)
Yes, n = 25 (41.7%)
HR (95%CI)
P value
No, n = 42 (70.0%)
Yes, n = 16 (26.7%)
HR (95%CI)
P value
Age, yr, mean ± SD67.4 ± 12.368.0 ± 12.31.00 (0.97-1.03)0.94567.3 ± 12.768.7 ± 11.01.00 (0.96-1.04)0.837
Gender, n (%)0.7020.185
Male16 (55.2)13 (44.8)Reference19 (65.5)10 (34.5)Reference
Female17 (58.6)12 (41.4)0.86 (0.39-1.88)23 (79.3)6 (20.7)0.50 (0.18-1.39)
Preop Hb, g/dL, mean ± SD11.28 11.93 1.16 (0.88-1.53)0.29611.4 ± 2.312.0 ± 2.51.14 (0.81-1.61)0.446
Preop glycemia, g/dL, mean ± SD1.08 ± 0.361.08 ± 0.311.72 (0.14-10.00)0.8841.06 ± 0.331.14 ± 0.351.47 (0.12-18.20)0.764
Preop total proteins, g/dL, mean ± SD6.7 ± 0.77.1 ± 0.81.33 (0.56-3.17)0.5146.9 ± 0.96.9 ± 0.50.87 (0.19-3.93)0.861
Preop CEA, n (%)0.8680.891
< 5 ng/mL6 (46.2)7 (53.8)Reference10 (76.9)3 (23.1)Reference
≥ 5 ng/mL4 (57.1)3 (42.9)0.89 (0.23-3.46)5 (71.4)2 (28.6)1.14 (0.18-7.14)
Missing23152711
BMI, mean ± SD26.3 ± 4.927.8 ± 4.71.04 (0.94-1.15)0.46527.6 ± 4.825.7 ± 4.60.96 (0.83-1.13)0.646
ASA, n (%)
13 (60)2 (40)Reference4 (80)1 (20)Reference
28 (42.1)11 (57.9)0.64 (0.15-2.75)0.54414 (73.7)5 (26.3)0.46 (0.06-3.38)0.447
313 (61.9)8 (38.1)0.34 (0.07-1.55)0.16315 (71.4)6 (28.6)0.31 (0.04-2.35)0.258
43 (100)0 (0.0)0.30 (0.01-7.69)0.4712 (66.7)1 (33.3)2.09 (0.16-27.56)0.573
Missing6473
Presentation with occlusion, n (%)0.4650.470
No5 (62.5)3 (37.5)Reference6 (75)2 (25)Reference
Yes6 (46.2)7 (53.8)1.58 (0.46-5.44)9 (69.2)4 (30.8)1.89 (0.34-10.61)
Missing23152711
Tumour site, n (%)
Right colon11 (68.7)5 (31.3)Reference13 (81.3)3 (18.7)Reference
Left colon11 (42.3)15 (57.7)2.48 (0.89-6.88)0.08120 (76.9)6 (23.1)1.73 (0.42-7.04)0.445
Rectum11 (68.7)5 (31.3)0.98 (0.28-3.41)0.9729 (56.3)7 (43.7)2.34 (0.59-9.32)0.226